AACR G.H.A. Clowes Memorial Award

Nominations for the 2009 Award will open in September 2008.

Nomination deadline: 4:00 p.m. United States Eastern Time on Wednesday, October 15, 2008

Learn more about the 2008 Award recipient, Dr. John E. Dick. View the list of all past winners.

The Award & Lecture

The AACR and Eli Lilly and Company established this Award in 1961 to honor Dr. G.H.A. Clowes, who was a founding member of the AACR and a research director of Eli Lilly. The Clowes Award recognizes an individual with outstanding recent accomplishments in basic cancer research.

The winner of the 49th Annual AACR G.H.A. Clowes Memorial Award will receive a $10,000 honorarium and will give a 50-minute lecture during the AACR Annual Meeting 2009 in Denver, CO, U.S.A. (April 18-22, 2009). The winner will also speak at the Eli Lilly and Company headquarters in Indianapolis, Indiana at the invitation of the company later in 2009.

Eligibility

• Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
• The Award will be presented to an individual investigator.
• Institutions or organizations are not eligible for the Award.
  
  

Nomination Process

Nominations may be made via letter from any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves.

Nomination letters must be sent electronically to the AACR by Wednesday, October 15, 2008 at 4:00 p.m., United States Eastern Time. Preferred file formats are *.doc, *.pdf. Your nomination is not considered fully submitted until you receive a confirmation e-mail from the AACR; confirmations will be sent within 2 business days.

The nomination letter must be addressed to the Selection Committee; be written in English; and not exceed 1,000 words. The content should include the following:

• the name of the AACR Award for which the candidate is being nominated;
  
• a brief statement of no more than 50-words summarizing the candidate's cancer research accomplishment(s) for which he or she is being nominated;
• a concise description of the candidate's outstanding recent accomplishments in basic cancer research, with the publications supporting these accomplishments directly referenced within the letter; and
• a concise description of the impact of these accomplishments on the field.

Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.

There is no restriction on the number of candidates that may be nominated by any individual scientist. There is no restriction on the number of nominators that may write nomination letters or that may sign a single nomination letter on behalf of a candidate.

Selection

Candidates will be considered by a Committee of international cancer leaders appointed by the President of the AACR. After careful deliberations by the Award Committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the Award winner will be made on the basis of the candidate’s recent accomplishments in basic cancer research. No regard will be given to age, race, gender, nationality, geographic location, or religious or political views.

Supporter

Generously supported by Eli Lilly and Company.

Questions?

Monique P. Eversley, Program Associate
monique.eversley@aacr.org 

American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA  19106-4404